Drugs / Purified hepatitis B surface antigen
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00501124 | May 2007 → Jul 2010 | chronic hepatitis B virus infection | Bukwang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purified hepatitis B surface antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00501124 ↗ |
| Modality | Vaccine | “monthly HBV vaccination” NCT00501124 ↗ |